Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,197 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Active, not recruiting

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

NCT05710406

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +13 more
Locations
  • Beebe South Coastal Health Campus Millville, Delaware, United States
  • Helen F Graham Cancer Center Newark, Delaware, United States
  • Medical Oncology Hematology Consultants PA Newark, Delaware, United States
  • Beebe Health Campus Rehoboth Beach, Delaware, United States
View all 202 locations
View Trial Details
Active, not recruiting

A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies

NCT05329766

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Santa Monica, California, United States
  • Research Site Derby, Connecticut, United States
View all 43 locations
View Trial Details
Active, not recruiting

Oncogenetic Panel and Integrated Clinical Data Registry Study for Wild Type Gastrointestinal Stromal Tumor Patients

NCT04821895

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +7 more
Locations
  • Chang Gung Memorial Hospital Kaohsiung City, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Kaohsiung Veterans General Hospital Kaohsiung City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
View Trial Details
Active, not recruiting

Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008).

NCT04895722

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
Locations
  • Mid Florida Cancer Center ( Site 1519) Orange City, Florida, United States
  • University Cancer & Blood Center, LLC ( Site 1521) Athens, Georgia, United States
  • University of Chicago Medical Center-Medicine - Section of Hematology/Oncology - Gastrointestinal P Chicago, Illinois, United States
  • Icahn School of Medicine at Mount Sinai ( Site 1528) New York, United States
View all 109 locations
View Trial Details

Related conditions